Literature DB >> 3320160

Effect of total lymphoid irradiation on IgE antibody responses in rheumatoid arthritis and systemic lupus erythematosus.

A I Terr1, R B Moss, S Strober.   

Abstract

Thirteen patients with rheumatoid arthritis and four patients with systemic lupus erythematosus and nephritis were treated with total lymphoid irradiation because of severe disease refractory to other forms of treatment. Serum samples before and after irradiation were tested for changes in total serum IgE and for changes in specific IgE antibodies to ryegrass pollen, dust mite, cat dander, and Alternaria. There were no statistically significant changes in total or specific IgE from lymphoid irradiation in these patients. The therapy caused a significant decrease in circulating total lymphocyte and Leu-3 (helper/inducer) T-lymphocyte counts. Therefore, reduction in circulating levels of helper/inducer T cells does not appear to influence preexisting levels of IgE antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320160     DOI: 10.1016/s0091-6749(87)80268-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Short-term preoperative radiotherapy in rectal cancer patients leads to a reduction of the detectable number of lymph nodes in resection specimens.

Authors:  K Maschuw; R Kress; A Ramaswamy; I Braun; P Langer; B Gerdes
Journal:  Langenbecks Arch Surg       Date:  2006-05-09       Impact factor: 3.445

2.  Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer.

Authors:  Daniel C Damin; Mário A Rosito; Paulo C Contu; Cláudio Tarta; Paulo R Ferreira; Lucia M Kliemann; Gilberto Schwartsmann
Journal:  J Gastrointest Surg       Date:  2012-05-23       Impact factor: 3.452

3.  Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation.

Authors:  H Bass; T Mosmann; S Strober
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.